Literature DB >> 8431659

Generation of natural killer cells from long-term cultures of mouse bone marrow.

F Vecchini1, D Delfino, K D Patrene, A DeLeo, L Lu, R B Herberman, S S Boggs.   

Abstract

The features of a mouse long-term bone marrow culture (LTBMC) system that produces natural killer (NK) cell activity are described. Over a 4-week period in the NK-LTBMC, cellularity dropped from approximately 2.5 x 10(7) to 8 x 10(5) cells/25-cm2 flask. About 3 x 10(5) of these cells were loosely adherent. The cultures at this time contained about one-third the spleen colony forming units, one-tenth the granulocyte macrophage colony forming units and about one-third the transplantable NK progenitor activity of fresh bone marrow (BM), and no detectable NK cell activity. In the 4-week NK-LTBMC, IL-2-responsive precursor cells appeared to be selectively maintained and gave an 8-fold higher activity after culture with human recombinant IL-2 (rIL-2) than did fresh BM. The addition of 50-5,000 IU/ml of rIL-2 resulted, after a minimal 3-day lag, in progressively increased cellularity for as long as 13 days. The percentage and staining intensity of NK-1.1+ cells increased with time after addition of rIL-2. CD3 epsilon + cells were occasionally seen and B220+ cells were present in low numbers at day 7 and slowly increased through day 13. The stroma was necessary for IL-2-dependent development of NK activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431659

Source DB:  PubMed          Journal:  Nat Immun        ISSN: 1018-8916


  2 in total

Review 1.  Murine natural killer cell differentiation: past, present, and future.

Authors:  T A Moore; M Bennett; V Kumar
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.

Authors:  S Qian; L Lu; F Fu; W Li; F Pan; R J Steptoe; F G Chambers; T E Starzl; J J Fung; A W Thomson
Journal:  Transplantation       Date:  1998-06-27       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.